Interleukin 3 (IL-3 or multi-colony-stimulating factor) plays an important role in the hematopoietic response to inflammatory stimuli through its action on both immature and mature blood cells. Like other lymphokines, IL-3 is produced in response to activation of the T-cell receptor and protein kinase C pathways. By using nuclear run-on assays of quiescent and stimulated T-cell lines, we demonstrate that IL-3 gene expression is controlled, at least in part, at the level of transcription. Functional reporter gene analysis was used to delineate two regions of the IL-3 5' flanking sequence responsible for transcriptional stimulation. DNA binding proteins that potentially mediate these responses were then recognized by mobility-shift and DNase footprinting assays. One region responsible for transcriptional enhancement was localized to the sequence GATGAATAAT, the cognate site of a transcription factor, here termed NF-IL3-A. A second region of functional activity and protein binding was localized to a single transcription factor AP-1 site. In addition three functionally inhibitory regions were identified. These results, along with the further characterization of NF-IL3-A, will contribute to the understanding of IL-3 gene regulation in stimulated T cells.
IL-3 is produced in response to activation of the T-cell receptor and protein kinase C pathways. By using nuclear run-on assays of quiescent and stimulated T-cell lines, we demonstrate that IL-3 gene expression is controlled, at least in part, at the level of transcription. Functional reporter gene analysis was used to delineate two regions of the IL-3 5' flanking sequence responsible for transcriptional stimulation. DNA binding proteins that potentially mediate these responses were then recognized by mobility-shift and DNase footprinting assays. One region responsible for transcriptional enhancement was localized to the sequence GATGAATAAT, the cognate site of a transcription factor, here termed NF-IL3-A. A second region of functional activity and protein binding was localized to a single transcription factor AP-1 site. In addition three functionally inhibitory regions were identified. These results, along with the further characterization of NF-IL3-A, will contribute to the understanding of IL-3 gene regulation in stimulated T cells.
Among the growth factors involved in hematopoiesis, interleukin 3 (IL-3 or multi-colony-stimulating factor) affects the widest variety of cell types. In conjunction with other growth factors, IL-3 acts on marrow-derived progenitor cells to stimulate the development of erythrocytes, granulocytes, macrophages, and megakaryocytes (1, 2) . In addition, it influences the growth and activation of lymphocytes (3) , promotes the self-renewal of hematopoietic progenitor cells (4) , and acts upon mature leukocytes to enhance their functional activity (5, 6) . In this way, IL-3 is thought to be involved in the host response to infectious, inflammatory, and immunologic stimuli.
Constitutive expression of IL-3 has not been observed in any normal cell yet examined. By using the polymerase chain reaction, mRNA specific for human IL-3 has been identified in a number of cell sources (7) , but IL-3 mRNA has only been found in T lymphocytes or T-cell lines treated with stimulators of the T-cell receptor or of the protein kinase C pathway (8) . The molecular basis for this highly inducible and selective tissue specificity is uncertain.
To further understand the regulation of IL-3 production, we have cloned the gene for human IL-3 and have performed a detailed analysis of the 682-base-pair (bp) region upstream of the start of IL-3 transcription. Our results suggest that IL-3 gene expression is controlled, at least in part, at the level of transcription and that binding of trans-acting factors at two distinct sites mediate much of this response.
MATERIALS AND METHODS
Cell Lines and Culture. The T-lymphocyte cell line Jurkat (ATCC), the cervical carcinoma cell line HeLa (ATCC), and the leukemia cell line AML-193 were maintained in Dulbecco's modified Eagle's medium supplemented with 10% (vol/ vol) fetal calf serum, glutamate, and antibiotics. The gibbon T-lymphocyte cell line MLA-144 (ATCC) was maintained in RPMI 1640 medium supplemented as noted above. AML-193 cells were also supplemented with recombinant human granulocyte/macrophage colony-stimulating factor.
Northern Blot Analysis. Whole cellular RNA was enriched for poly(A)-containing transcripts by chromatography on oligo(dT)-cellulose, size-fractionated by formaldehyde/ agarose gel electrophoresis, and transferred to nitrocellulose (9) . The blots were hybridized with full-length cDNA probes for gibbon IL-3 (10), murine c-jun (11), human cAMPresponsive element binding protein (CREB) (12), bovine 13-actin (13) , and a 1.1-kilobase fragment containing the first exon of the human c-fos gene (14) , all labeled by random priming (Amersham), or with oligonucleotides for human JUN-B [bases 709-738 (sequence kindly provided by Richard Turner, University of California, San Francisco)] and human CRE-BP-1 [bases 73-96 (15)] labeled with [y-32P]ATP by polynucleotide kinase. The blots were washed twice at 20'C and twice at 650C in 0.2x SSC/0.1% NaDodSO4 (1x SSC = 0.15 M NaCI/0.015 M sodium citrate, pH 7.0) for the cDNA and genomic probes or in 3 M tetramethylammonium chloride at 680C or 620C for the 30-or 24-bp oligonucleotide probes, respectively (16) .
Nuclear Run-On Analysis. Cell lines were grown to 1 X 106 cells per ml and then stimulated with concanavalin A (Con A;
Boehringer Mannheim) at 10 gg/ml and phorbol 12-myrisitate 13-acetate (PMA; Sigma) (100 ng/ml) for 15 min to 24 hr. Cells were washed and lysed, and labeled run-on transcripts were produced from the resultant nuclei as described (9) . Antisense single-stranded cDNA for gibbon IL-3 (10), human granulocyte/macrophage-colony-stimulating factor (17), human 8-actin (18) , and M13 were slot-blotted, prehybridized, and then hybridized for 72 hr at 650C with an equal amount of radioactivity of each of the run-on RNAs (9) . The blots were washed twice at 20'C and twice at 650C in 0.1x SSC/0.1% NaDodSO4 and then exposed to film. Proc. Nati. Acad. Sci. USA 87 (1990) 9651 using this site, fragments of the 5' IL-3 flanking region of successively larger size were linked to a clone of the bacterial chloramphenicol acetyltransferase (CAT) gene. These promoter-reporter constructs were assembled in pUC18 by using standard techniques and were numbered according to the nucleotide size of the promoter construct counting from the cap site. All constructions were sequenced for confirmation.
Electroporation and Functional Analysis. Cells were washed and resuspended in Hepes-buffered saline (30 mM Hepes, pH 7.05/137 mM NaCl/5 mM KCI/10 mM sodium phosphate) at 1 x 107 cells per ml along with 20 ,ug of each construct DNA and 10 ,ug of the plasmid vector RSV-/3-Gal (to provide a control for the relative efficiency of transfection). Electroporation was carried out using the Cellporator device (BRL) with 750 V/cm for 9 msec at 20'C. The cells were then divided and cultured in control medium or medium supplemented with Con A (10 pug/ml) and PMA (100 ng/ml). After culture for 1 (MLA) or 3 (Jurkat) days, cell lysates were assayed for CAT and fB-galactosidase activity and calculated as described (9) .
Mobility-Shift and DNase I Footprinting Assays. Nuclear extracts were prepared according to Dignam et al. (20) . Duplex oligonucleotides representing various regions of the IL-3 promoter (see Fig. 2B ) were end-labeled with [y_32p]_ ATP by using polynucleotide kinase. Nuclear extract (10 ,ug) or purified recombinant c-jun protein (20 ng) was preincubated with 50 ng of competitor duplex oligonucleotide in 10 ,Al of binding buffer [10 mM Hepes, pH 7.9/50 mM NaCI/3% (vol/vol) glycerol/1.25 mM EDTA/2 mM dithiothreitol/ poly(dI-dC) (0.1 mg/ml)] for 15 min and then 1 ng of 32P-labeled duplex oligonucleotide was added and the reaction was incubated for an additional 20 min at 20°C. The reaction products were fractionated by electrophoresis through 4% polyacrylamide gels (50 mM Tris, pH 8.3/400 mM glycine/2 mM EDTA) at 100 V. The gels were dried and exposed to film. DNase I (Worthington) protection assays were performed as described (21) in 50-,ld reaction mixtures containing mobility-shift assay buffer, 25 ,ug of nuclear extract, and 1 ng of a Stu I-Sma I (positions -313 to -59) fragment of the IL-3 promoter end-labeled with [y-32P]ATP. Digestion products were size-fractionated on 6% acrylamide/urea sequencing gels adjacent to sequencing reaction products. RESULTS
Nuclear Run-On Analysis. To determine the mechanisms that contribute to the regulation of IL-3 gene expression, Northern blot analysis was performed on Jurkat and MLA cells. IL-3-specific transcripts were detected within 90 min to 6 hr of mitogenic stimulation (Fig. 1) . By using nuclear run-on analysis, both T-cell lines were observed to actively transcribe the IL-3 gene within 2 hr of stimulation. Transcription appeared to peak at 6 hr but was still present at 24 hr. (Fig. 2B ).
The precise location of the first (positions -161 to -126) element and its importance to the functional activity of the promoter was confirmed by mutating the IL-3 flanking sequence between positions -156 and -147 to a random sequence (Fig. 2B, construct 356NFIL3A-) . This mutation nearly eliminated inducible reporter gene activity. In contrast, mutation of the CREB binding site immediately downstream of this position increased reporter gene activity (construct 161CREB1)
To determine whether the two regions that act in cis to augment reporter gene activity confer inducibility upon a heterologous promoter, the 5' flanking region of IL-3 gene was cloned upstream of the major late promoter of adenovirus (mlp) and the CAT gene. In six experiments, addition of the sequence between positions -313 and -59 upstream of the cap site resulted in a 12.9-fold inducibility of the mlp in response to T-cell stimulation, compared with a 1.6-fold induction with these agents in a construct containing the mlp and CAT alone. No CAT activity was detectable when only the IL-3 sequence and CAT were present.
In addition to the two enhancing regions, three potential negative regulatory sites are also apparent in the IL-3 5' flanking region. Addition of the regions between positions -313 and -397, positions -161 and -272, and positions -59 and -116 resulted in reproducible decreases in reporter gene activity in stimulated Jurkat cells. Extending the promoter analysis through position -682 resulted in promoter activity similar to that for construct 397 (data not shown).
Nudear Proteins that Bind to the IL-3 Promoter. Oligonucleotides based upon the sequence of several regions of the human IL-3 gene (Figs. 2 and 3) were tested in mobility-shift assays. Specific retarded bands were consistently produced by extracts from both Jurkat and MLA cells using an oligonucleotide containing the sequence between bases -160 and -130 (Fig. 3A) . This region shares sequence similarities with the CREB (12, 15) and the IL-2 enhancer elements NFAT-1 (Fig. 3B) . To confirm the precise binding site DNase I footprinting was performed. As shown in Fig. 3C , nucleotides between 157 and 144 bp upstream of the cap site were protected from digestion in the presence of T-cell nuclear extracts.
A second specific band pattern was obtained using an oligonucleotide pair matching the IL-3 sequence from positions -308 to -276, a region that contains an AP-1 binding site (11) . As shown in Fig. 4 failed to eliminate the enhancement of reporter gene activity detected in this region. (ii) Oligonucleotides that contain the CREB or the NFAT-1 binding sites were unable to displace specific binding to this IL-3 gene sequence and did not produce similar bands when tested in mobility-shift assays (data not shown). (iii) By using Northern blot analysis, no specific CREB transcripts could be detected in stimulated Jurkat or MLA cell RNA. In addition to binding nuclear proteins, this site is functionally active as its mutation 1 2 3 4 5 6 7 8 9 (22, 27) and suggests that NF-IL3-A may be related to the octomer binding proteins.
A second region involved in the transcriptional regulation of IL-3 maps to an AP-1 site located at position -301. This sequence binds a family of proteins that includes the protooncogenes c-jun and c-fos and the related genes JUN-B and JUN-D (11, 14) . Several , and appears to be protected in our footprinting assays using T-cell nuclear extracts (Fig. 3C) , The functional significance of this region, however, is uncertain and warrants further study. The presence of these binding activities in unstimulated cells, albeit at a lower level than in stimulated T-lymphocyte nuclear extracts, does not necessarily militate against a role for these proteins in the transcriptional activation of the IL-3 gene. Additional alterations, such as protein phosphorylation or enhanced binding affinity, not detectable by mobility-shift or DNase footprinting assays may be responsible for transcriptional activation (27, 29, 30) .
Finally, despite the presence of a number of consensus sequences for characterized DNA binding proteins, the first 126 bp of the IL-3 gene 5' flanking region displays a minimal response in the presence of mitogenic stimulation. Two of these sequences, termed CK-1 and CK-2 by Shannon et al. (23) , are present beginning at positions -126 and -115, respectively. A second CK-1 site is also present at position -333 of the IL-3 5' flanking region. In addition, the decanucleotide sequence beginning at position -74 matches the consensus transcription factor AP-2 binding site proposed by Imagawa et al. (24) at all 10 positions, and the decanucleotide sequences beginning at positions -96 and -90 match this consensus sequence at 8 positions. Comparison of the reporter gene activities of constructs that flank the CK-1 and CK-2 site, constructs 126 vs. 116 and constructs 116 vs. 107, respectively, or of the constructs that flank the consensus AP-2 sites, constructs 107 vs. 59, revealed minimal modulation of CAT activity across these sites in the 5' flanking region of the IL-3 gene. Thus, the functional significance of the CK-1, CK-2, and AP-2 sites cannot be determined from their presence alone. It is possible that these elements require additional upstream sequences to exert an influence on transcription. Additional deletion mutations of these regions will be required to determine whether CK-1, CK-2, and AP-2 are functionally involved in the regulation of IL-3 gene expression in T lymphocytes.
In this study we have focused upon the regions responsible for up-regulation of IL-3 transcription in T lymphocytes. We have described sequences present in the 5' flanking region of the IL-3 gene that act in cis and nuclear proteins that bind to these regions and appear to participate in this process. One of these factors, AP-1, has been extensively characterized in other systems. The other factor is a protein present in both control and mitogen-stimulated T cells. A more complete characterization of this putative transcriptional regulator awaits studies in nonlymphoid cell systems, in vivo crosslinking of nuclear proteins to transfected DNA fragments, and, of course, its genomic cloning. Along with further characterization of the down-modulating elements, these studies should provide a better understanding of the regulation of IL-3 gene expression in human T lymphocytes. 
